October 26, 2020 — The ACTIV-3 clinical trial evaluating the investigational monoclonal antibody LY-CoV555 in hospitalized patients with COVID-19 will
Continue reading »
Home »
Alexion Receives FDA Approval for New Advanced Formulation of Ultomiris (ravulizumab-cwvz) with Significantly Reduced Infusion Time
BOSTON–(BUSINESS WIRE)–Oct. 12, 2020– Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (FDA) has approved Ultomiris
Continue reading »
FDA Authorises Restart of the COVID-19 AZD1222 Vaccine US Phase III Trial
23 October 2020 — Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed across the world with regulators
Continue reading »
FDA Approves Veklury
FDA Approves Veklury (remdesivir) for the Treatment of COVID-19 FOSTER CITY, Calif.–(BUSINESS WIRE)–Oct. 22, 2020– Gilead Sciences, Inc. (Nasdaq: GILD)
Continue reading »
Moderna Announces Initiation of Rolling Submission to Health Canada for mRNA Vaccine Against COVID-19 (mRNA-1273)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oct. 13, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create
Continue reading »Anapolon (Oxymetholone) – plus 60 pounds of muscles mass per month
Anapolon (Anapolon Ultra, Androlik, Anapolan, Dynasten, Androver, Sinasteron, Oxiged) – the active substance Oxymetholone, is an anabolic drug that promotes
Continue reading »
World-first testing strategy for penicillin
New research led by The University of Western Australia will lead to a world-first in testing strategy for penicillin allergy
Continue reading »
Metabolic syndrome: New use for an old drug
New drugs can be developed from old ones. This revolutionary pharmacological approach was confirmed by a study published today in
Continue reading »
A Canadian essential medicines list must be evidence-based
An essential medicines list in Canada should be evidence-based and independent of conflicting interests, found a study of decision-makers and
Continue reading »
Cannabidiol gel reduces seizures in children with severe epilepsy, Australasian trial shows
A cannabidiol gel has been shown to reduce epileptic seizures in children in a clinical trial conducted in New Zealand
Continue reading »